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Abstract A comparative study on human telomeric DNA
G-quadruplex binding of meso-5,10,15,20-tetrakis(N-meth-
yl-4-pyridyl)porphyrin (TMPyP4) between its two salt forms,
i.e., tetratosylate and tetrachloride, was conducted by using
ESI-TOF-MS, UV-melting measurement, and molecular
modeling methods. Besides cation TMPyP4, the tosyl anion
was found to bind to human telomeric DNA G-quadruplex
with multiple binding stoichiometries from 1:1 to 3:1 ob-
served in ESI-TOF-MS spectra, indicating that the stabiliza-
tion activity of TMPyP4 tetratosylate on G-quadruplex is
derived from a synergetic effect of both TMPyP4 cation and
tosyl anion. A molecular modeling study suggests that a tosyl
anion fills up the vacant space between TMPyP4 cation and
DNA G-quadruplex and thus stabilizes the complex by
3.8 kcal/mol. Therefore, it is estimated that TMPyP4
tetratosylate’s activity might not reflect the real effect of
TMPyP4 cation in some bioassays related to G-quadruplex
stabilization. This was verified by the results of less binding
affinity of TMPyP4 tetrachloride with DNA G-quadruplex
obtained from ESI-TOF-MS measurement, and of 2.27 °C
less thermal stabilization of TMPyP4 tetrachloride for DNA
G-quadruplex, compared to its tetratosylate under the same
conditions. Our study demonstrated the influence of counter
ions of TMPyP4 on G-quadruplex binding, which sheds light
on the proper usage of TMPyP4 salt in the chemical and
biological research associated with G-quadruplex binding.
Subsequently, the binding of TMPyP4 tetrachloride to human
telomeric RNAG-quadruplexes was studied with ESI-TOF-MS
technique. The binding constants of TMPyP4 with human
telomeric G-quadruplexes indicated that TMPyP4 binds to
human telomeric RNA G-quadruplex one order of magnitude
stronger than DNA counterpart. This is a comprehensive mass
spectrometric report on binding study of TMPyP4with human
telomeric DNA/RNA G-quadruplexes.
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Introduction
As a wide spectrum of G-quadruplex binder, meso-
5,10,15,20-tetrakis(N-methyl-4-pyridyl)porphyrin (TMPyP4,
see Electronic Supplementary Material Fig. S1) has been
extensively studied in the aspects of G-quadruplex binding
[1–6] and inducing activities [7, 8], telomerase inhibition [1,
3, 9–12], and anticancer effects [10–14]. The antitumor activ-
ity of TMPyP4 tetratosylate (see Electronic Supplementary
Material Fig. S1) has been examined in K562 leukemic cells,
retinoblastoma cell lines, and osteosarcoma cell lines.
Regarding the mechanism of its anticancer activity, it has been
show that TMPyP4 tetratosylate significantly inhibited tel-
omerase activity in telomerase positive HOS and Saos-2 cells,
induced telomere shortening, and inhibited the cell growth in
HOS and Saos-2 cells with over 17 % apoptosis rates. These
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indicated that antitumor effect of TMPyP4 may be related to
telomere dysfunction through G-quadruplex stabilization
[14].
It was noted that TMPyP4 has been mostly used in its salt
form of tetratosylate from commercial supplier as a G-
quadruplex ligand in many literature reports [2, 12–21]. The
counter ion tosyl may contribute to G-quadruplex stabilization
effect of TMPyP4 due to a consideration that its planar mol-
ecule may also interact with G-quadruplex. To attest our
prediction, G-quadruplex binding study was conducted be-
tween two salt forms of TMPyP4, i.e., tetratosylate and tetra-
chloride, by using ESI-QTOF-MS, UV-melting measurement,
and molecular modeling studies. The G-quadruplex binding
affinities of these two salt forms of TMPyP4 with human
telomeric DNA were compared. In addition, G-quadruplex
binding activity of TMPyP4 tetrachloride was also quantita-
tively compared between two types of human telomeric
G-quadruplexes, i.e., DNA and its RNA anologue, for a
purpose of exploring its binding specificity with nucleic
acid G-quadruplexes.
Experimental procedures
Sample preparation Amberlite® IRA-400 (Cl) ion exchange
resin was purchased from Aldrich Chemical Company.
TMPyP4 tetratosylate from Sigma-Aldrich (USA) was con-
verted to the tetrachloride salt as follows. TMPyP4
tetratosylate (5 mg) dissolved in Milli-Q water was loaded to
an Amberlite® IRA-400 (Cl) ion exchange resin column
(2.5 cm×15 cm) and eluted with Milli-Q water to afford
TMPyP4 tetrachloride (2.32 mg) with a yield of 75.1 %.
TMPyP4 tetrachloride was identified by 1H-NMR technique
(see Electronic Supplementary Material Fig. S2).
ESI-TOF-MS spectrometry All ESI-TOF-MS experiments
were performed on a Bruker MicrOTOF-Q mass spectrome-
ter. The experimental conditions were optimized to avoid
denaturation of the G-quadruplex species. The capillary volt-
age was +3,500 V and the dry gas N2 flow was 4.0 L/min at
100 °C. The analyzer was operated at a background pressure
of 3×10−7 mbar. The rate of sample infusion into the mass
spectrometer was 3 μL/min. Data were analyzed with the
instrument software Bruker Daltonics DataAnalysis. All
nucleic acid oligomers (desalted grade) d[(TTAGGG)4TTA]
(M=8496.6 Da) and r[(UUAGGG)4UUA] (M=8789.3 Da)
were purchased from Invitrogen (Japan) and used without
further purification. The stock solutions of all nucleic acid
oligomers were prepared in Milli-Q water at the concentration
of 1 mM, and further diluted by 1 M NH4OAc buffer (pH 7.6)
to the desired concentration. All stock solutions of TMPyP4
were prepared in Milli-Q water with a concentration of
400 μM. The samples of an equal molar mixture of DNA/
RNA oligomer and TMPyP4 were prepared in 100 mM
NH4OAc (pH 7.6), and then were kept in room temperature
for 30 min. A final strand concentration of 5 μM (or 10 μM)
DNA/RNA oligomer and 5 μM (or 10 μM) TMPyP4 in
50 mM NH4OAc (pH 7.6) containing 50 % methanol were
flow injected into mass spectrometer for the measurement of
binding affinity [22, 23].
ESI-QTOF-MS spectrometry All QTOF-MS/MS experiments
were carried out on a Bruker maXis impact mass spectrometer
in the negative mode. The source parameters were optimized
as follows: capillary voltage of +3,500 V, nebulizer of 1.5 bar,
dry gas flow of 4.0 L/min at 160 °C, and end plate offset
voltage of 500 V. The tune parameters were set as follows:
400 Vpp of funnel 1 RF, funnel 2 RF, and hexapole RF for
transfer parameters; 5 eV of ion energy and 350m/z of low
mass for quadrupole parameters; 10 eV of collision energy,
1,500 Vpp of collision RF, 180 μs of transfer time, and 16 μs
of prepulse storage time for collision cell parameters; 0.1 Hz
of spectra rate, mass range from 300 to 3,000m/z, and 20 Da
of width for MS/MS parameters. Each QTOF-MS/MS spec-
trum was an average of at least 30 scans.
UV-melting measurement Thermal denaturation was carried
out in 25 mM Tris–HCl buffer (pH 7.4) containing 100 mM
KCl on a UV-2700 spectrometer (Shimadzu, Japan) equipped
with a Shimadzu TMSPC-8 temperature controller. The ab-
sorbance was determined at 295 nm, while the temperature
was programmed to increase from 20 to 95 °C with a heating
rate of 1 °C/min. The DNA concentration was 5 μM for the
ΔTm measurements of dAGGG(TTAGGG)3 in the absence or
presence of either TMPyP4 tetratosylate or TMPyP4 tetra-
chloride in a 2:1 ligand/DNA molar ratio. The melting tem-
perature (Tm) was the average value from three independent
measurements [24].
Molecular modeling Binding mode of TMPyP4 cation and
tosyl anion to the human telomeric DNA G-quadruplex was
derived through molecular modeling. A three-dimensional
structure of human telomeric DNA G-quadruplex in the
Protein Data Bank (PDB entry 2JPZ) [25] was used as the
template to construct the structural model of the DNA G-
quadruplex used in our experimental study. Molecular
docking of TMPyP4 cation to G-quadruplex was performed
by using the GLIDE module in the Schrödinger software
(version 9.3.5, released by the Schrödinger Inc.). The binding
pocket was defined to consist of residues A3, A15, G16, and
A21, which locates roughly at the top of the 5′-terminal of the
G-quadruplex. The size of the binding pocket was set to 20Å.
The GlideScore scoring function in the SP mode was applied
to evaluate possible binding poses of TMPyP4 cation. Only
the binding pose with the highest binding score was selected
for further consideration. On account of G-quadruplex is
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negatively charged and TMPyP4 positively charged, the tosyl
anion was manually docked upon the position of TMPyP4
cation (Figs. 1 and 2).
The two models of TMPyP4 cation in complex with
G-quadruplex (with or without the tosyl anion) were
then refined by molecular dynamics (MD) simulations.
BothMD jobs were conducted by using the AMBER program
(version 12, released by UCSF). Small-molecule ligands (i.e.,
TMPyP4 and tosyl) were prepared by the Antechamber mod-
ule in AMBER. Atomic partial charges on small-molecule
ligands and G-quadruplexes were both computed with the
Gaussian software (version 03, released by the Gaussian Inc)
at the HF/6-31G* level and then assigned by the RESP meth-
od. All ionizable bases on the G-quadruplexes were set at their
default deprotonation states at a neutral pH. A number of
counter ions were added to neutralize the whole molecular
system. The whole complex was then soaked at the center of a
TIP3Pwater box with a margin of 10 Å along each dimension.
After minimization of the whole system, a MD simulation of
20 ns long was conducted for each complex at a constant
pressure of 1 atm and a constant temperature of 300 K.
The time interval in each MD job was set to 2 fs. The
SHAKE method was applied to restrict all covalent bonds
connecting hydrogen atoms on small-molecule ligands as well
Fig. 1 Negative ESI-TOF-MS spectra of human telomeric DNA se-
quence d[(TTAGGG)4TTA] (Q) alone (a), with equimolar mixture of
TMPyP4 tetratosylate (b), and TMPyP4 tetrachloride (c). Spectra were
recorded with 1:1 DNA-to-drug molar ratio (C=10 μM) in 50 mM
ammonium acetate buffer (pH 7.6) containing 50 % methanol. [1:1]5−
means the complex of Q and TMPyP4 cation of 1:1 molar ratio in −5
charge state; [1:2]5− means the complex of Q and TMPyP4 cation of 1:2
molar ratio in −5 charge state, and similarly as to the others. The symbol
*, **, and *** represent the number of tosyl adducts 1, 2, and 3,
respectively
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Fig. 2 Negative ESI-QTOF-MS/MS spectra of human telomeric DNA
G-quadruplex (Q) precursor ions at m/z 1,705.0665 (a), 1:1:1 complex of
G-quadruplex:TMPyP4:tosyl anion atm/z 1873.9137 (b), 1:2 complex of
G-quadruplex:TMPyP4 at m/z 1970.8779 (c), and 1:1 complex of G-
quadruplex :TMPyP4 at m/z 1836.0705 (d). Spectra were recorded with
1:1 molar ratio (C=50 μM) of d[(TTAGGG)4TTA] and TMPyP4
tetratosylate in 10 mM ammonium acetate buffer (pH 7.6) containing
50 %methanol. The collision energy was 25 eV for a–c, and 35 eV for d.
[1:1]5−means the complex of Q and TMPyP4 cation of 1:1 molar ratio in
the −5 charge state, and similarly as to the others. Asterisk represents the
tosyl anion adduct. The inserts in c and d are the enlargement of [1:1]5−
and [Q]5−, respectively
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as G-quadruplex. In addition, a harmonic restraint of
50 kcal/mol Å2 was applied to all heavy atoms on G-
quadruplex. Potential energies were calculated by using the
AMBER FF10 force field with a nonbonded distance cutoff of
10Å. The ParticleMesh Ewald (PME)methodwas adopted to
compute long-range electrostatic interactions. The last snap-
shot on each resulting MD trajectory was retrieved as the final
complex model shown in Fig. 4.
Based on the obtained MD trajectories of two TMPyP4/G-
quadruplex complexes, the MM-GB/SA method in AMBER
was employed to compute the binding free energy between
TMPyP4 cation and G-quadruplex with and without the pres-
ence of the tosyl anion. A total of 1,000 snapshots were
retrieved from the 10–20-ns segment on each MD trajectory
with an interval of 10 ps. Binding free energies were comput-
ed on this configuration ensemble, and the average value was
recorded as the final result.
Results
Binding of two salt forms of TMPyP4 to human telomeric
DNA G-quadruplex
ESI-TOF-MS is a powerful tool for directly observing the
binding affinity of small molecules with biomolecules such
as DNA and RNA. This effective and rapid analytical
technique has been playing an active role in the investigations of
noncovalent complexes involving biopolymers [26]. Moreover,
binding constants for ligands with oligodeoxynucleotides in-
cluding G-quadruplex has been reliably measured by
ESI-MS [27, 28].
In order to directly observe the influence of tosyl group on
the G-quadruplex binding of TMPyP4, ESI-TOF-MS was
utilized to examine the binding of TMPyP4 tetratosylate with
human telomeric DNA G-quadruplex d[(TTAGGG)4TTA].
As illustrated in Fig. 1, the ESI-TOF-MS spectrum of
telomeric DNA d[(TTAGGG)4TTA] showed that adding of
the NH4OAc buffer facilitated the detection of quadruplex
(Q5− in Fig. 1a) [24] in the predominant −5 charge state
ion at m/z 1,705.0401, which corresponds to two NH4
+ ion
adducts of the oligodeoxynucleotide d[(TTAGGG)4TTA].
This indicated that G-quadruplex can maintain their structure
in gas phase because two ammonium cations were
sandwiched between three G-tetrads of the G-quadruplex
structure [29–32]. When TMPyP4 tetratosylate was added to
above G-quadruplex DNA (Fig. 1b), 1:1 and 1:2 complex
peaks of G-quadruplex with TMPyP4 cation were observed
in three charge states of −4, −5, and −6. Interestingly, a series
of tosyl adducts were simultaneously detected in both
TMPyP4-free G-quadruplex and TMPyP4-G-quadruplex
complexes with multiple binding stoichiometries from 1:1 to
3:1, indicating that tosyl anion additionally contributed to
G-quadruplex stabilization effect of TMPyP4 tetratosylate.
QTOF-MS/MS was utilized to further identify the nature of
the above complexes (Fig. 2). As shown in Fig. 2a, the pre-
cursor ion of free G-quadruplex at 1,705.0665 (with 2 ammo-
niums adducts) generated 2 daughter ions at 1,701.5393 (with
1 ammonium adduct) and 1,698.5505 (without ammonium
ion) under the collision energy of 25 eV. The MS/MS of the
1:1:1 complex of G-quadruplex:TMPyP4:tosyl anion at m/z
1,873.9137 under the collision energy of 25 eV produced
daughter ions of 1:1 G-quadruplex-TMPyP4 complex with
0–2 ammonium adducts in the charge state of −5 (at m/z of
1,840.7173, 1,836.6714, and 1,833.1813, respectively) and −4
(atm/z of 2,300.5044, 2,296.2540, and 2,292.0044, respective-
ly), but without any daughter ions of the free G-quadruplex
(Fig. 2b). The daughter ions of 1:1 complex of G-quadruplex
and TMPyP4 were also produced by the MS/MS of the pre-
cursor ion of 1:2 complex of G-quadruplex and TMPyP4 at
m/z 1,970.8779 with the collision energy of 25 eV (Fig. 2c).
When a collision energy of at least 35 eV was used to the
precursor ion of 1:1 complex of G-quadruplex-TMPyP4 at
m/z 1,836.0705, daughter ions of the free G-quadruplex
(at m/z 1,698.4364, 1,701.9505, and 1,705.5519) can be ob-
served (Fig. 2d), indicating that a higher collision energy is
required to break away the TMPyP4 cation from the 1:1
complex of G-quadruplex-TMPyP4. In order to investigate
the real binding of TMPyP4 cation with G-quadruplex, the
counter ion of tosyl in the commercial agent TMPyP4
tetratosylate was replaced by chloride ion by an Amberlite®
IRA-400 (Cl) ion exchange column chromatography. The
binding study of TMPyP4 tetrachloride to human telomeric
DNA G-quadruplex was subsequently carried out under the
same ESI-TOF-MS condition as that for TMPyP4
tetratosylate (Fig. 1c). To compare the G-quadruplex binding
affinity of two salt forms of TMPyP4 with human telomeric
sequence, the fraction of bound G-quadruplex, i.e., the peak
area ratio of all [complex] to total G-quadruplex ([complex]
and [free G-quadruplex]) [27, 33, 34], was used to evaluate the
relative binding affinities (RBA; Fig. 3). As shown in Fig. 3,
Fig. 3 The fraction of bound G-quadruplex of TMPyP4 tetratosylate and
TMPyP4 tetrachloride with human telomeric DNA G-quadruplex (n=3)
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TMPyP4 tetrachloride displayed a relatively less binding af-
finity than that of TMPyP4 tetratosylate, which was regarded
to be ascribable to the contribution of tosyl anion’s binding to
DNAG-quadruplex. To provide supporting evidence, the UV-
melting measurement was utilized to compare the thermal
stabilizing effect of two salts of TMPyP4 on the DNA G-
quadruplex. As a result (see Electronic Supplementary
Material Fig. S3), the melting temperature (Tm) of DNA G-
quadruplex was increased 6.45 and 4.18 °C by TMPyP4
tetratosylate and its tetrachloride, respectively, under the same
condition. An extra increase of 2.27 °C by TMPyP4
tetratosylate in the ΔTm of DNA G-quadruplex further con-
firmed that the tosyl anion contributes to the stabilizing effect
of TMPyP4 tetratosylate on DNA G-quadruplex. Our molec-
ular dynamics simulations showed that a tosyl anion tends to
stay inside a narrow groove on the surface of G-quadruplex
and beside where TMPyP4 cation binds (Fig. 4). The tosyl
anion fills up the vacant space between G-quadruplex and
TMPyP4 and thus stabilizes the whole complex.
Indeed, computed binding energy of TMPyP4 to G-
quadruplex in the presence of the tosyl anion
(−31.4 kcal/mol) is 3.8 kcal/mol lower than the result
of the same complex when the tosyl anion is absent
(−27.6 kcal/mol). Therefore, it indicates that TMPyP4
tetratosylate may not be an appropriate positive control used
as a G-quadruplex ligand in bioassays, especially for the
quantitative measurements, such as solution measurement by
kinetic analysis methods including UV–VIS spectrophotom-
etry [15–17], CD spectroscopy [16, 17, 21], surface plasmon
resonance (SPR), and DNA polymerase stop assay [18] etc.,
as well as the antitumor assay involving G-quadruplex stabi-
lization of TMPyP4 [12–14]. An inorganic salt form of
TMPyP4, such as its tetrachloride [1, 3, 5, 6], reflecting the
real interaction of TMPyP4 cation with G-quadruplex, should
be employed as G-quadruplex binder for quantitative assays.
Binding of TMPyP4 to human telomeric RNA G-quadruplex
Recently, it was reported that human telomeric repeat-
containing RNA sequence r(UUAGGG)4 also folds into a
parallel G-quadruplex in solution which is more stable than
its DNA counterparts [35–38]. RNA G-quadruplexes are
present in transcripts associated with telomeres and play
important roles in key cellular functions, including telo-
mere homeostasis and gene expression [39]. Since
TMPyP4 tetrachloride is recommended as a better pos-
itive control for G-quadruplex-related bioassay on the
basis of our ESI-TOF-MS, UV-melting, and molecular
modeling results, the binding of TMPyP4 tetrachloride
with human telomeric RNA G-quadruplex r[(UUAG
GG)4UUA] was therefore studied under the same ESI-TOF-
MS condition as that for DNA counterpart for a comparative
purpose. As shown in the ESI-TOF-MS spectrum of
r[(UUAGGG)4UUA] (Fig. 5a), the two predominant ions with
m/z value of 1,469.3221 and 1,763.3793 correspond to two
NH4
+ ion adducts of r[(UUAGGG)4UUA] in the charge state
of −6 and −5, respectively. This suggested the high stability of
RNA G-quadruplex in the gas phase. After adding an equal
molar of TMPyP4 tetrachloride to RNA G-quadruplex
(Fig. 5b), the complex of [1:1] and [1:2] stoichiometries of
G-quadruplex with TMPyP4 became predominant peaks,
while the free RNA G-quadruplex presents in very minor
peaks, showing the extremely strong binding of TMPyP4 with
RNA G-quadruplex.
In order to quantitatively compare the binding capacity of
TMPyP4 cation between two types of G-quadruplex, i.e., hu-
man telomeric RNA G-quadruplex and its DNA counterpart,
the equilibrium association constants K1 and K2 of TMPyP4
with both human telomeric RNA and DNA G-quadruplexes
were calculated according to the literature method [27]. The
relative intensities or peak areas of the free and bound G-
quadruplex in the mass spectra are assumed to be proportional
to the relative abundances of these species in solution. As the
initial concentrations are known, the concentrations of all indi-
vidual species at equilibrium (free G-quadruplex, 1:1 complex,
1:2 complex, and by difference, the free ligand) can be deter-
mined from the relative intensities or peak areas of the free G-
quadruplex and the complexes. Therefore, the equilibrium
association constants K1 and K2 were calculated directly from
the following Eqs. 1 and 2, respectively [27].
K1 ¼ 1 : 1 complex½ = free G−quadruplex½  free drug½ ð Þ ð1Þ
K2 ¼ 1 : 2 complex½ = 1 : 1 complex½  free drug½ ð Þ ð2Þ
The binding constants were determined at an equimolar
mixture of TMPyP4 tetrachloride and G-quadruplex
(10 μM:10 μM and 5 μM:5 μM, respectively). As a
result (Table 1), binding affinities (K1 and K2) of
TMPyP4 with RNA G-quadruplex were at least tenfold
higher than those with DNA G-quadruplex. The binding
affinities (K1) 1.87×10
6 M−1 and (K2) 2.83×10
5 M−1 of
TMPyP4 with human telomeric DNA G-quadruplex calculat-
ed by ESI-TOF-MS analysis were almost consistent with
those reported (K1) 2×10
6 M−1 and (K2) 5×10
5 M−1 by ITC
experiments [40]. This indicated that the binding affinity
measured by gas-phase method of ESI-TOF-MS is compara-
ble to that acquired by solution-phase method.
Discussion
The binding of commercial telomerase inhibitor TMPyP4
tetratosylate with human telomeric DNA G-quadruplex was
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examined by ESI-TOF-MS technique in this study. The coun-
ter ion tosyl was found to bind to G-quadruplex DNA in a
series of multiple binding stoichiometries from 1:1 to 3:1,
which contributes to 13.68 % (85.96–72.28 %) RBA value
of TMPyP4 tetratosylate more than that of its tetrachloride.
UV-melting study showed that TMPyP4 tetratosylate in-
creased 2.27 °C more than its tetrachloride in the ΔTm value
of DNA G-quadruplex, further supporting the contribution of
tosyl anions to the thermal stability of TMPyP4-bound DNA
G-quadruplex. The computed binding energy of the 1:1:1
complex of G-quadruplex:TMPyP4:tosyl anion is favorable
by −3.8 kcal/mol as compared to the result of the 1:1 complex
of DNA G-quadruplex with TMPyP4. This finding alerts that
the commercial TMPyP4 tetratosylate may not be a suitable
Fig. 4 Structural models of
TMPyP4 binding with human
telomeric G-quadruplex in the
absence (a) and presence (b) of
one tosyl ion, which were derived
through molecular dynamics
simulations. Computed binding
energies of TMPyP4 with
telomeric G-quadruplex are −27.6
(a) and −31.4 kcal/mol (b),
respectively. TMPyP4 and tosyl
ion are shown in the ball-and-
stick model, whereas telomeric
G-quadruplex is shown in the
molecular surface model
Fig. 5 Negative ESI-TOF-MS spectra of human telomeric RNA se-
quence r[(UUAGGGG)4UUA] (Q) alone (a) and with equimolar mixture
of TMPyP4 tetrachloride (b). Spectra were recorded with 1:1 RNA-to-
TMPyP4 molar ratio (C=10 μM) in 50 mM ammonium acetate buffer
(pH 7.6) containing 50 % methanol. [1:1]5−means the complex of Q and
TMPyP4 cation of 1:1 molar ratio in −5 charge state; [1:2]5− means the
complex of Q and TMPyP4 cation of 1:2 molar ratio in −5 charge state,
and similarly as to the others
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agent used for TMPyP4’s bioassays related to G-quadruplex
stabilization [12–19], and proposed the usage of TMPyP4
tetrachloride as a better one for G-quadruplex research.
Our study demonstrated the influence of counter ions of
TMPyP4 on G-quadruplex binding, which shed light on
the proper usage of TMPyP4 salt in the chemical and
biological research associated with G-quadruplex binding. It
should be mentioned that it is worthwhile to explore the
influences of different counter ions (tosylate and chloride)
on biological and pharmacological activity of TMPyP4
in G-quadruplex-related bioassays, such as antitumor and
cytotoxic assays.
In addition, the binding of TMPyP4 tetrachloride with both
human telomeric DNA and RNA G-quadruplexes was also
quantitatively carried out by ESI-TOF-MS analysis. Both 1:1
and 2:1 binding stoichiometries were observed for TMPyP4
binding to two types of G-quadruplexes. The binding con-
stants (K1) and (K2) of TMPyP4 tetrachloride with DNA G-
quadruplex derived from ESI-TOF-MS analysis were almost
consistent with those obtained by solution method of ITC
experiments [40], indicating that ESI-TOF-MS analysis is an
alternative method to reliably measure G-quadruplex binding
constant. The binding constant of K1 is one order of magni-
tude stronger than K2 for TMPyP4 tetrachloride binding to
human telomeric DNA and RNA G-quadruplexes. A similar
case was reported for TMPyP4 binding to a human c-kit proto-
oncogene DNA G-quadruplex with a strong binding constant
(K1) around 10
7, and a weak K2 around 10
6 [41]. The first
binding event (K1) is typical of an interaction via end stacking
[29, 40, 42], while the second binding event (K2) is probably
due to the interaction via groove or external loop binding [41,
42]. The QTOF-MS/MS results supported the above specula-
tion that a higher collision energy of at least 35 eV is required
to break away the TMPyP4 cation from the precursor ion of
1:1 complex of G-quadruplex-TMPyP4 (Fig. 2d), while a
weaker collision energy of 25 eV is enough to drive out one
TMPyP4 cation with the weaker G-quadruplex-binding affin-
ity from the precursor ion of 1:2 complex of G-quadruplex-
TMPyP4 (Fig. 2c). In addition, no any daughter ions of the
free G-quadruplex were detected in Fig. 2c, indicating that the
collision energy of 25 eV is too weak to simultaneously
exclude two TMPyP4 cations from the precursor ion of 1:2
complex of G-quadruplex-TMPyP4.
ESI-TOF-MS is a powerful and reliable analytical
tool in the study of the noncovalent interactions be-
tween TMPyP4 and nucleic acids with inherent advantages
of speed, specificity, sensitivity, and stoichiometry [21,
22, 24, 26–28], compared with the conventional spec-
troscopic methods such as UV spectrophotometry,
fluorospectrophotometry and circular dichroism [2, 6, 8,
15–18, 43], etc. Firstly, the rapid measurement of a mass
spectrum within 2 min allows the accurate determination
and direct observation of binding stoichiometries of
TMPyP4 with nucleic acids, which is impossible by the
methods of UV spectrophotometry, fluorospectrophotometry,
and circular dichroism. Secondly, the high-resolution
ESI-MS data show great superiority of precisely sorting
out all different species of nucleic acids simultaneously,
which provides more comprehensive information on the
binding of TMPyP4 cation and tosyl anion with nucleic
acids. But only the weighted contribution of all species
present in solution is measured in the conventional
spectroscopic methods. Thirdly, the relative binding af-
finities or even equilibrium constants obtained by ESI-
TOF-MS usually match closely the ranking order obtained
from other solution methods. Finally, QTOF-MS/MS can
help to identify the nature of complexes of drugwith nucleic
acids.
Conclusion
Based on the results obtained from ESI-TOF-MS, ESI-QTOF-
MS/MS, UV-melting measurement, and molecular modeling,
it was concluded that the tosyl anion of commercial TMPyP4
tetratosylate contributes to the G-quadruplex stabilizing effect.
This finding shed light on the proper usage of TMPyP4
salt in the chemical and biological research associated
with G-quadruplex binding. In this study, ESI-TOF-MS
technique provided direct evidence that TMPyP4 cation
binds to DNA/RNA G-quadruplex with both 1:1 and 2:1
binding stoichiometries. Moreover, the binding capacity of
TMPyP4 tetrachloride with human telomeric RNA G-
quadruplex was one order of magnitude stronger than that
with DNA counterpart. This is a comprehensive and compar-
ative mass spectrometric report on binding study of TMPyP4
with human telomeric DNA/RNA G-quadruplexes.
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